People with PTSD may soon have MDMA treatment option pending FDA decision. Allegations of research misconduct could delay approval timeline.
FDA to decide on MDMA approval for PTSD based on extensive research. Concerns arise about validity of the results leading to potential delays.
[
add
]
[
|
|
...
]